Targeting Crlz-1: new peptide therapy shows antilymphoma effects
March 4, 2025
The nuclear protein charged amino acid-rich leucine zipper 1 (Crlz-1) has been shown to play a role in the rapid proliferative stages of B-cell development, being targeted by the canonical Wnt/β-catenin signaling pathway.